First New Fibromyalgia Drug in 15 Years: Tonix's Tonmya Approved for 10M+ US Patients After Strong Trial Results - Stock Titan

Tonmya, a non-opioid sublingual tablet, showed significant pain reduction in 1,000+ patient trials. Targets 10M+ US adults with fibromyalgia. Commercial launch set for Q4 2025.